Jiuyou Capital
Jiuyo Capital is a venture capital firm established in 2015 and headquartered in Shenzhen, China. The firm focuses on early to pre-IPO investments across various sectors, with a particular emphasis on hard and core technology, biotechnology, and advanced manufacturing. Jiuyo Capital primarily invests in innovative fields such as photoelectric chips, robotics, aerospace, life sciences, and high-end medical equipment. In biotechnology, its investment strategy targets innovative drugs, precision medicine, and medical devices, with a focus on small molecules, proteins, nucleic acids, and cell therapies addressing conditions such as cancer and metabolic diseases. Additionally, in the technology sector, Jiuyo Capital is interested in areas like 5G technology, semiconductors, the Internet of Things, artificial intelligence, and intelligent manufacturing. With strong connections in private equity, public funds, and other financial institutions, Jiuyo Capital aims to enhance the investment ecosystem in China.
Jisi Yingda is a small-molecule anti-cancer drug developer, in the field of small-molecule tumor immune drugs and tumor drug development.
OakMega is a provider of cross-platform CRM solutions on messaging apps for marketing experts. Driven by honest values, and win-win mentality in their culture, OakMega is out to connect brands and people with human touch.
Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on the development of small molecule drugs for cancer, viral infections, and autoimmune diseases.
Sinovent Inc. is a biopharmaceutical company founded in 2016 and headquartered in Suzhou, China, with additional offices in Beijing and Boston. The company focuses on innovation in healthcare by utilizing an advanced biotechnology platform and leveraging extensive management experience and financial resources. Sinovent is dedicated to developing and promoting treatment methods to address global health challenges. Currently, the firm has 12 products in various stages of development, targeting therapeutic areas such as oncology, autoimmune diseases, and infectious diseases. Through its commitment to research and development, Sinovent aims to provide effective medical solutions to improve patient health outcomes.
Developer and researcher of biopharmaceuticals for molecular nuclear oncology intended to serve the biotechnology industry. The company specializes in developing innovative biological drug products including both diagnostics and therapeutics formulations targeting molecular oncology, providing reliable and effective products for better cancer treatment.
Developer and manufacturer of millimeter wave radar detection systems designed for drone robots, automobiles, and security systems. The company's technology include millimeter-wave radar sensors and advanced driver assistance systems (ADAS), enabling enterprises to utilize quality sensor systems in their application, increasing safety and efficiency.
Denovo Biopharma is a privately held biotechnology company based in Hangzhou, China, specializing in biopharmaceuticals. The company offers a unique biomarker solution aimed at personalizing drug development. Its core technology is the first platform and algorithm designed for de novo genomic biomarker discovery, utilizing archived clinical samples to identify biomarkers that correlate with patient responsiveness to drug candidates. This capability is particularly beneficial for late-stage clinical drugs that have previously shown unsatisfactory efficacy. By enabling the identification of relevant biomarkers retrospectively, Denovo Biopharma assists biotech and pharmaceutical companies in designing new clinical trials targeted at specific patient populations, ultimately aiming to enhance drug efficacy and reduce adverse effects. The company's platform has broad applications across various therapeutic areas, including oncology, metabolic disorders, cardiology, immunology, and neurology.
Tianbing Technology
Angel Round in 2019
Tianbing Technology is an advanced aerospace propulsion system supplier and aerospace vehicle provider. Tianbing Technology independently develops the next-generation ambient temperature green HCP liquid propellant and minimalist aerospace propulsion system. As an upgraded product of traditional chemical propulsion system, it can meet cost-effective aerospace. Advance system supporting needs. The next-generation green HCP aerospace propulsion system, first tested by Tianbing Technology, can be used in the small-vehicle main power and launch vehicle upper-level propulsion system.
Stemirna Therapeutics Co., Ltd. is a biotechnology company based in Shanghai, China, founded in 2016. The company specializes in developing mRNA technology-based drug solutions, with a focus on personalized cancer vaccines, mRNA vaccines for infectious diseases, and treatments for genetic and protein defect diseases. Stemirna has established a comprehensive mRNA drug platform that includes a GMP production center and a tumor neoantigen library, along with a clinical cooperation platform for mRNA drug development. With more than a dozen independently-developed projects, Stemirna aims to harness the potential of RNA science to provide safe and effective therapeutic options for patients suffering from various medical conditions.
Tianbing Technology
Angel Round in 2019
Tianbing Technology is an advanced aerospace propulsion system supplier and aerospace vehicle provider. Tianbing Technology independently develops the next-generation ambient temperature green HCP liquid propellant and minimalist aerospace propulsion system. As an upgraded product of traditional chemical propulsion system, it can meet cost-effective aerospace. Advance system supporting needs. The next-generation green HCP aerospace propulsion system, first tested by Tianbing Technology, can be used in the small-vehicle main power and launch vehicle upper-level propulsion system.
SenseFuture
Angel Round in 2019
SenseFuture is a laser radar technology developer, focusing on providing laser radar and machine vision fusion solutions for robots and unmanned vehicles. Based on the detection performance of photoelectric algorithms, it can meet the needs of unmanned environment perception. Beijing Weisen Technology Co., Ltd., which is a robot and unmanned sensory, provides fusion sensing solutions such as laser radar and vision. The company was registered in May 2018. Prior to this, relying on the talent team and environmental platform of Peking University,they have accumulated 2 years of research results in the field of laser radar.
Beijing Tianyishangjia New Material Corp., Ltd. researches and develops, produces, and markets brake pads and brake block series products for high-speed trains, EMU, rolling stock, urban rail transit vehicles. Its products include sintered brake pads, sintered brake shoes, organic brake pads, organic brake shoes, brake blocks, and other products. The company was founded in 2009 and is based in Beijing, China.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.